Med Ed Report briefs
Merck and Schering-Plough spent around $60 million from 2004 to 2008 on CME around cardiovascular topics, according to Dow Jones Newswires. The figures came from the Senate Special Committee on Aging, whose chairman, Sen. Herb Kohl (D-WI), cited them as evidence that “when drug companies fund CME, they see it as money well spent on marketing their latest blockbuster drug.”
Sen. Chuck Grassley (R-IA) wrote NIH acting director Raynard Kingston to prod him to look into ghostwriting by Wyeth and Agency DesignWrite, as alleged in an August New York Times piece. Grassley demanded to know the agency's current policy on ghostwriting with regards to NIH researchers, grantee institutions and primary investigators of NIH grants.